Advertisement

Topics

Canadian Pharmacare Report Urges Mandatory Substitution

06:16 EDT 14 Jun 2019 | SCRIP

Recommendations by Canada’s advisory council implementing national pharmacare include mandatory generic substitution and also mechanisms of biosimilar substitution.

      

Related Stories

 

Original Article: Canadian Pharmacare Report Urges Mandatory Substitution

NEXT ARTICLE

More From BioPortfolio on "Canadian Pharmacare Report Urges Mandatory Substitution"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...